According to data from the National Institute on Minority Health and Health Disparities, Louisiana had the eighth-highest ...

Cancer incidence is rising around the world, but an international study is challenging the popular narrative that young ...

The 5-year lung cancer survival rate has increased more than 25% over the past decade, highlighting the impact of increased ...

Top U.S. cancer centers have launched a federated AI platform, letting models learn from patient data securely to accelerate ...

The incidence of central nervous system cancer in the US remains largely unchanged from 1990 to 2021, while disability ...

Cancer health tech company Flatiron Health has unveiled six new blood cancer data sets that together comprise information ...

People diagnosed with advanced breast cancer in 2025 can expect to live for an extra six or seven months, compared to the ...

DermaSensor announced newly published studies supporting the performance of its device for evaluating suspicious skin lesions ...

The American Cancer Society (ACS) today announced the inaugural release of The U.S. Tobacco Atlas, a fact-based, digital ...

A sustained reduction in deaths from prostate cancer was observed with prostate-specific antigen (PSA) testing in long-term ...

Park says patient-specific factors that influence his treatment selection include the presence of liver disease, ...

Iovance Biotherapeutics shares rose after the company received positive data from a clinical trial of its cancer treatment. Shares traded 11% higher ahead of the morning bell at $2.18.